journal article Open Access Apr 01, 2026

Direct estimation of activity concentration in regional voxels with application to 177 Lu peptide receptor radionuclide therapy

Medical Physics Vol. 53 No. 4 · Wiley
Abstract
Abstract

Background
Quantitative SPECT in radionuclide‐therapy is limited by partial‐volume effects (PVEs). The implementation of regional voxels (r.v.), estimating mean activity concentrations in regions directly from projections, offers a promising alternative for the geometry‐specification to reduce PVEs.


Purpose

This study aims to demonstrate that activity‐concentration estimation with r.v. is superior to reconstruction with cuboid voxels (cu.v.) with post‐reconstruction partial‐volume correction (PVC) for estimation of activity concentration in
177
Lu peptide receptor radionuclide therapy (
177
Lu‐PRRT).



Methods

Data originated from one patient administered [
177
Lu]Lu‐DOTA‐TOC with SPECT acquired at 1 d, 4 d and 7 d p.i. stored in list‐mode format (dataset PA), and eight patients given [
177
Lu]Lu‐DOTA‐TATE with SPECT acquired 1 d p.i. (dataset PB). Activity concentration was estimated from reconstruction with cu.v. and using r.v. for both datasets, with multiple noise realizations for PA using bootstrapping. Organ delineation was performed based on CT using the AI tool TotalSegmentator, and tumor delineation made in cu.v. SPECT images. The estimated activity concentration for kidneys, spleen, and tumors from r.v. was compared to that obtained with cu.v. with and without post‐reconstruction PVC. To study the accuracy of activity‐concentration estimates, simulations were performed with the SIMIND Monte Carlo program with patient images used as basis. The sensitivity to misalignments between SPECT and CT was also evaluated.



Results

For both patient and simulated data, activity concentrations estimated with r.v. are higher than those from cu.v., with comparable standard deviations. Mean relative errors for simulated images from PA relative to simulation input at 1 d p.i. reconstructions with r.v. are (−4.6 
± 
1.4) %, (3.0 
± 
0.5) %, (0.1 
± 
0.5) %, and (5.6 
± 
1.2) % for tumor, left kidney, right kidney, and spleen, respectively. Corresponding results for cu.v. with post‐reconstruction PVC are (−12.3 
± 
2.2) %, (‐4.2 
± 
0.6) %, (−7.0 
± 
0.5) %, and (‐2.1 
± 
1.1) %. For simulated images based on PB, the mean relative errors obtained for r.v. are (−3.1 
± 
3.5) %, (1.2 
± 
1.2) %, (−1.7 
± 
1.1) %, and (2.3 
± 
0.8) %, while for cu.v. with PVC they are (−7.9 
± 
6.7) %, (‐5.8 
± 
1.9) %, (−9.0 
± 
1.0) %, and (‐0.7 
± 
2.6) %.



Conclusions

Regional voxels are superior to cu.v. for estimation of the activity concentration in organs in
177
Lu‐PRRT and demonstrates lower sensitivity to misregistration errors. For tumors, r.v. yields lower systematic errors than cu.v. but demonstrates a higher sensitivity to image segmentation errors for volumes below approximately 10 mL.
Topics

No keywords indexed for this article. Browse by subject →

References
51
[30]
De Ro J (2018)
[32]
TotalSegmentator: Robust Segmentation of 104 Anatomic Structures in CT Images

Jakob Wasserthal, Hanns-Christian Breit, Manfred T. Meyer et al.

Radiology: Artificial Intelligence 10.1148/ryai.230024
[34]
Frey EC (1996)
[37]
scikit-image: image processing in Python

Stéfan van der Walt, Johannes L. Schönberger, Juan Nunez-Iglesias et al.

PeerJ 10.7717/peerj.453
[39]
MarkwardtCB.Non‐linear least squares fitting in IDL with MPFIT.2008:
[50]
Örbom A "The intratumoral distribution of radiolabeled 177Lu‐BR96 monoclonal antibodies changes in relation to tumor histology over time in a syngeneic rat colon carcinoma model" J Nucl Med (2013) 10.2967/jnumed.112.117028

Showing 50 of 51 references

Metrics
0
Citations
51
References
Details
Published
Apr 01, 2026
Vol/Issue
53(4)
License
View
Funding
Cancerfonden Award: 243785Pj01H
Fru Berta Kamprads Stiftelse Award: FBKS‐2024–7‐583
Cite This Article
Johan Gustafsson, Erik Larsson, Katarina Sjögreen Gleisner (2026). Direct estimation of activity concentration in regional voxels with application to 177 Lu peptide receptor radionuclide therapy. Medical Physics, 53(4). https://doi.org/10.1002/mp.70424